Ocular Chloramphenicol and Aplastic Anemia

F. T. Fraunfelder, Grover C. Bagby

Research output: Contribution to journalLetterpeer-review

12 Scopus citations


To the Editor: Since the report of possibly the fourth major adverse hemopoietic event associated with topical ocular chloramphenicol,* there have been six additional possible cases reported to the National Registry of Drug-Induced Ocular Side Effects (Oregon Health Sciences University, Portland). Some of these cases were reported to the Registry because the physician only recently remembered that his or her patient with aplastic anemia had been exposed four to six months previously to topical ocular chloramphenicol. Although it is not possible to establish a definite cause- and-elfect relation between topical ocular chloramphenicol and bone-marrow failure, topical ocular chloramphenicol is easily.

Original languageEnglish (US)
Number of pages1
JournalNew England Journal of Medicine
Issue number25
StatePublished - Jun 23 1983

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Ocular Chloramphenicol and Aplastic Anemia'. Together they form a unique fingerprint.

Cite this